21-(ACETYLOXY)-9,11-DICHLORO-16-METHYL-17-((1-OXOPENTYL)OXY)PREGNA-1,4-DIENE-3,20-DIONE, (11.BETA.,16.ALPHA.)-
UNII 275180LIWM
Substance Identification & Data
This profile provides standardized clinical and technical data for 21-(acetyloxy)-9,11-dichloro-16-methyl-17-((1-oxopentyl)oxy)pregna-1,4-diene-3,20-dione, (11.beta.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 275180LIWM.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 15047-41-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H38Cl2O6 QZQOLBFFBCYZDR-GQGOTNMPSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 21-(acetyloxy)-9,11-dichloro-16-methyl-17-((1-oxopentyl)oxy)pregna-1,4-diene-3,20-dione, (11.beta.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.